Network Pharmacology and Molecular Docking Study of Yupingfeng Powder in the Treatment of Allergic Diseases

被引:6
|
作者
Qu, Minye [1 ]
Tao, Wenhua [1 ]
Ma, Jian [2 ]
机构
[1] Jiangsu Univ, Clin Med Coll 1, Dept Tradit Chinese Med, Zhenjiang, Peoples R China
[2] Nanjing Univ Chinese Med, Basic Med Coll, Dept Warm Dis, Nanjing, Peoples R China
基金
中国国家自然科学基金;
关键词
TRADITIONAL CHINESE MEDICINE; ATOPIC-DERMATITIS; TH17; LYMPHOCYTES; CELL SUBSETS; ASTHMA; CYTOKINES; IL-17; RECOMMENDATIONS; RELEASE; WOGONIN;
D O I
10.1155/2022/1323744
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective. To explore the potential mechanisms of Yupingfeng Powder (YPFP) in the treatment of allergic diseases by using network pharmacology and molecular docking technology. Methods. The active components and targets of YPFP were screened by the TCMSP database. The targets associated with atopic dermatitis, asthma, allergic rhinitis, and food allergy were obtained from GeneCards and OMIM databases, respectively. The intersection of the above disease-related targets was identified as allergy-related targets. Then, allergy-related targets and YPFP-related targets were crossed to obtain the potential targets of YPFP for allergy treatment. A protein-protein-interaction (PPI) network and a drug-target-disease topology network were constructed to screen hub targets and key ingredients. Next, GO and KEGG pathway enrichment analyses were performed separately on the potential targets and hub targets to identify the biological processes and signaling pathways involved. Finally, molecular docking was conducted to verify the binding affinity between key ingredients and hub targets. Results. In this study, 45 active ingredients were identified from YPFP, and 48 allergy-related targets were predicted by network pharmacology. IL6, TNF, IL1B, PTGS2, CXCL8, JUN, CCL2, IL10, IFNG, and IL4 were screened as hub targets by the PPI network. However, quercetin, kaempferol, wogonin, formononetin, and 7-O-methylisomucronulatol were identified as key ingredients by the drug-target-disease topological network. GO and KEGG pathway enrichment analysis indicated that the therapeutic effect of YPFP on allergy involved multiple biological processes and signaling pathways, including positive regulation of fever generation, positive regulation of neuroinflammatory response, vascular endothelial growth factor production, negative regulation of cytokine production involved in immune response, positive regulation of mononuclear cell migration, type 2 immune response, and negative regulation of lipid storage. Molecular docking verified that all the key ingredients had good binding affinity with hub targets. Conclusion. This study revealed the key ingredients, hub targets, and potential mechanisms of YPFP antiallergy, and these data can provide some theoretical basis for subsequent allergy treatment and drug development.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Molecular mechanism of lycorine in the treatment of glioblastoma based on network pharmacology and molecular docking
    Su, Jie
    Huo, Mengmeng
    Xu, Fengnan
    Ding, Liqiong
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (03) : 1551 - 1559
  • [22] Exploring the Molecular Mechanism of Action of Yinchen Wuling Powder for the Treatment of Hyperlipidemia, Using Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation
    Ye, Jiahao
    Li, Lin
    Hu, Zhixi
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [23] Potential Material Basis of Yupingfeng Powder for the Prevention and Treatment of 2019 Novel Coronavirus Pneumonia: A Study Involving Molecular Docking and Molecular Dynamic Simulation Technology
    Yu, Ying
    Zhang, Gong
    Han, Tao
    Liu, Hongjie
    Huang, Hailiang
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [24] Study on mechanism of transdermal administration of eugenol for pain treatment by network pharmacology and molecular docking technology
    Ye, Haoting
    Lin, Qiuxiao
    Mei, Qinghua
    Liu, Qiuqiong
    Cao, Siwei
    HELIYON, 2024, 10 (08)
  • [25] Study on the mechanism of ErtongKe granules in the treatment of cough using network pharmacology and molecular docking technology
    Chen, Yu-Long
    Li, Wei-Xia
    Zhang, Hui
    Wang, Xiao-Yan
    Zhang, Shu-Qi
    Zhang, Ming-Liang
    Han, Jun
    Li, Kun
    Feng, Ke-Ran
    Chen, Xiao-Fei
    Tang, Jin-Fa
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (11) : 11415 - 11429
  • [26] Molecular docking and network pharmacology study on active compounds of Cyprus rotundus for the treatment of diabetes mellitus
    Vishakha Desai
    Mohammad Ziyad Shaikhsurab
    Nimmy Varghese
    Harsha Ashtekar
    In Silico Pharmacology, 12 (2)
  • [27] Network Pharmacology, Molecular Docking, Molecular Dynamics to Explore the Mechanism of Danggui Shaoyao Powder for Hepatic Encephalopathy
    Zhang, Miao
    Liu, Rongxin
    Zhao, Yusen
    Chen, Zixin
    Zhai, Honglin
    Si, Hongzong
    CURRENT PHARMACEUTICAL DESIGN, 2025,
  • [28] Network Pharmacology and Molecular Docking Study of the Chinese Miao Medicine Sidaxue in the Treatment of Rheumatoid Arthritis
    Wu, Ning
    Yuan, Taohua
    Yin, ZhiXin
    Yuan, Xiaotian
    Sun, Jianfei
    Wu, Zunqiu
    Zhang, Qilong
    Redshaw, Carl
    Yang, Shenggang
    Dai, Xiaotian
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 435 - 466
  • [29] Network pharmacology and molecular docking study on the active ingredients of qidengmingmu capsule for the treatment of diabetic retinopathy
    Zhang, Mingxu
    Yang, Jiawei
    Zhao, Xiulan
    Zhao, Ying
    Zhu, Siquan
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [30] Exploring the mechanism of avenanthramide in the treatment of atherosclerosis based on network pharmacology and molecular docking: An observational study
    Wang, Zhigang
    Fang, Longzhi
    Han, Meng
    Liu, Kangzhe
    Zheng, Yuanmei
    Zhan, Yibei
    MEDICINE, 2024, 103 (51)